Kabra Drugs Share Price
12 Aug, 2026 4:01 PM (IST)
Kabra Drugs Performance
- Today's Low
- ₹24
- Today's High
- ₹26
- 52 Week Low
- ₹16
- 52 Week High
- ₹36
- Open Price₹24
- Previous Close₹24
- Volume219,794
- 50 DMA₹23.80
- 100 DMA₹24.40
- 200 DMA₹23.80
Kabra Drugs Chart
Investment Returns
- Over 1 Month + 15.3%
- Over 3 Month -6.57%
- Over 6 Month -26.26%
- Over 1 Year + 19.2%
Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!
Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 7.8
- PEG Ratio
- 0
- Market Cap Cr
- 59
- P/B Ratio
- 2
- Average True Range
- 1.7
- EPS
- 3.2
- Dividend Yield
- 0
- MACD Signal
- 0.3
- RSI
- 59.69
- MFI
- 75.38
Latest Stock News Updates
Resignation of director of Ms. Anand Anitha
- BSE India
- 3 hours 45 minutes ago
Undertaking for Non-Applicability of Reg 32
- BSE India
- 4 hours 7 minutes ago
Undertaking for Non-Applicability of Reg 32
- BSE India
- 4 hours 7 minutes ago
Kabra Drugs Financials
Kabra Drugs Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹23.80
- 50 Day
- ₹23.80
- 100 Day
- ₹24.40
- 200 Day
- ₹23.80
Resistance and Support
- R3 28.30
- R2 27.30
- R1 26.10
- S1 24.00
- S2 22.90
- S3 21.80
Kabra Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-12 | Quarterly Results | |
| 2026-05-29 | Quarterly Results | |
| 2026-05-06 | Others | Inter-alia, to consider 1. Pharmaceutical manufacturing & marketing expansion of own brands. 2. Defense & AI Integration: To evaluate opportunities in defense manufacturing. 3. Other business matters. |
| 2026-04-21 | Others | Inter-alia, to consider 1. Appointment of Ms. Monam Kapoor as Additional Director. 2. Board will discuss the amendment of the Main Objects clause of the MOA. 3. Notice of POM. 4.Other business matters |
| 2026-03-07 | Others | Inter-alia, to consider 1. Proposal for changing the name of the company. 2. Strategic expansion of business operations in Indonesia and Canada. 3. Other business matters. |
About Kabra Drugs
Kabra Drugs is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. View More- NSE Symbol
- KABRADG
- BSE Symbol
- 524322
- ISIN
- INE323K01017
Similar Stocks to Kabra Drugs
Popular Stocks
Kabra Drugs FAQs
Kabra Drugs share price is ₹25 As on 12 August, 2026 | 23:21
The Market Cap of Kabra Drugs is ₹59.3 Cr As on 12 August, 2026 | 23:21
The P/E ratio of Kabra Drugs is 7.8 As on 12 August, 2026 | 23:21
The PB ratio of Kabra Drugs is 2 As on 12 August, 2026 | 23:21
The 52 week High & Low of Kabra Drugs is ₹35.5/₹15.5 respectively As on 12 August, 2026 | 23:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.